# 2 PAM Autoinjectors

Canonical: https://abierto.us/opportunities/2pambarda

- Solicitation number: 2-PAM-BARDA
- Notice type: Sources sought
- Status: Closed. Deadline was May 14, 2025 at 4:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Office of Assistant Secretary for Preparedness and Response
- Contracting office: Barda - Aspr / Daappo / Barda DCMA (75A501)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance: Washington, District of Columbia
- County: District of Columbia (FIPS 11001). https://abierto.us/counties/district-of-columbia-dc-11001
- City: Washington. https://abierto.us/cities/washington-dc-1150000
- First posted: April 22, 2025
- Last posted: April 22, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/028451b7e45b4bcab1eb112d1934f2f5/view

## Description

BARDA seeks pertinent marketplace data on availabilities and capabilities for procuring, stockpiling, and investing in the late-stage development of Pralidoxime (2-pyridine aldoxime methyl chloride; 2-PAM) autoinjectors for intramuscular injection. BARDA seeks information on availability, capabilities, and other pertinent marketplace data to support late-stage activities required for Food and Drug Administration (FDA) approval of 2-PAM (600 mg) autoinjectors.

## Publications

- April 22, 2025: Sources sought, due May 14, 2025 at 4:00 PM EDT. Notice 028451b7e45b4bcab1eb112d1934f2f5. https://sam.gov/workspace/contract/opp/028451b7e45b4bcab1eb112d1934f2f5/view

## Points of contact

- Kevin Dean, Contracting Specialist, kevin.dean1@hhs.gov, 2029895371
- Erin Greninger, Contracting Officer, erin.greninger@hhs.gov, 7712107767

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/2pambarda.